FDA approves Glenmark’s generic Hailey Fe 1/20
The Food and Drug Administration has approved Glenmark Pharmaceuticals’ generic of Allergan’s Hailey Fe 1/20 norethindrone acetate, 1 mg, and ethinyl estradiol, 20 mcg) tablets.
The drug is indicated to prevent pregnancy. It had U.S. brand and generic sales of roughly $116.8 million, according to data from IQVIA for the 12 months ended September 2017.
Glenmark said that its portfolio currently consists of 129 products in the United States, with a further 58 applications pending FDA approval.
Ajanta launches generic Kapvay
Ajanta Pharma has launched its generic of Concordia Pharmaceuticals’ Kapvay (clonidine hydrochloride) extended-release tablets. The Mumbai-based company’s launch of the product follows the Food and Drug Administration approving it on Tuesday.
The drug is indicated to treat attention deficit hyperactivity disorder as a monotherapy and as adjunctive treatment to stimulants. Ajanta’s generic will be available in 0.1-mg dosage strength.
CHPA recognizes Bayer for aspirin campaign
Bayer Aspirin has been named the recipient of the Consumer Healthcare Products Association 2017 Industry Leadership Award for Advancing Self-Care. This recognition comes from the New Jersey-based company’s “The HeroSmiths” marketing campaign, which was aimed to educate people of the life-saving benefits of aspirin during a suspected heart attack.
“Building a movement based on consumer needs and one that blends education with action is the epitome of advancing responsible self-care, and it’s an honor for us to be recognized,” Natalie Bartner, president of Bayer Consumer Health in North America, said. “The HeroSmiths campaign has the potential to quite literally save lives, and we’re proud that Bayer aspirin can help people become heroes.”
Each year the Consumer Healthcare Products Association (CPHA) awards one member in the company with the prestigious Industry Leadership Award for Advancing Responsible Self-Care, honoring the educational efforts that have created positive impact on the consumer healthcare industry.
According to a study done by the Second International Study of Infarct Survival Collaborative Group, during a suspected heart attack chewing aspirin as directed by a doctor can help increase chances of survival. The “HeroSmiths” program which launched back in Feb. 2007, brings awareness to this and carries the message of carrying aspirin everywhere in the event that someone nearby suffers from a heart attack.